Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.7413.438.0324.0616.71

What is the latest EV/Core EBITDA ratio of TTK HEALTHCARE ?

The latest EV/Core EBITDA ratio of TTK HEALTHCARE is 8.74 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20258.74
Mar202413.43
Mar20238.03
Mar202224.06
Mar202116.71

How is EV/Core EBITDA of TTK HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2025 8.74
-34.92
Mar2024 13.43
67.25
Mar2023 8.03
-66.63
Mar2022 24.06
43.99
Mar2021 16.71 -

Other Financial Ratios of TTK HEALTHCARE


Compare EV/Core EBITDA ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,645.8 Cr -1.2% -2.3% -28.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,822.0 Cr 1.6% 8.2% -8.8% Stock Analytics
DIVIS LABORATORIES ₹172,811.0 Cr -0.8% 14.4% 12.2% Stock Analytics
CIPLA ₹127,688.0 Cr -3.9% 5.5% 5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,840.0 Cr -0.5% 1% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.1% -0% -2% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-1.2%

-2.3%

-28.8%

SENSEX

0.7%

4.7%

6.1%


You may also like the below Video Courses